Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms)


Attention: There is an updated edition available for this report.

This report, Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms)  covers the market for NGS including a market estimate and a projection to 2020, regional growth for North America, Europe and Other regions, markets by disease category and instrument popularity from lab self reporting surveys.   The report also covers investments in sequencing, trends and detail about manufacturers and service companies in NGS.   A unique feature of this report is its focus on the interplay between in vitro diagnostics (IVD) and sequencing, with detailed examples of diagnostic companies and clinical laboratories that have made agreements in next generation sequencing.  Illumina, Thermo Fisher and other companies are analyzed in the report.  


    • Executive Summary
      • Overview
      • Scope and Methodology
      • Market Overview
        • Table Worldwide Sequencing Market Product Revenues (Instruments and Consumables), 2015 and 2020 (millions USD)
      • Future Prospects in the Sequencing Market
    • Introduction
      • Overview - Next Generation Sequencing Market Is Rapidly Changing
      • History of DNA Sequencing
      • Point-of-View
    • Sequencing Technology
      • Sanger Sequencing
      • Next-Generation Sequencing
        • Massively Parallel Signature Sequencing (MPSS)
        • Pyrosequencing
        • 454 Technology
        • Sequencing by Synthesis (SBS)
        • Supported Oligonucleotide Ligation and Detection (SOLiD)
        • Ion Torrent Sequencing
        • Single Molecule Real Time (SMRT) Sequencing
        • DNA Nano Ball Sequencing
        • Nanopore Sequencing
        • Other Sequencing Technologies
          • Table Current and Emerging Sequencing Technologies and Platforms
      • Sequencing Applications/Types of Sequencing
      • Sample or Library Preparation
        • Table Selected Companies Developing/Marketing Products for NGS Sample or Library Preparation
      • Information Technology
        • Table Selected Companies Developing/Marketing NGS Information Technology Solutions
      • Sample-to-Answer (Sample-to-Insight) Workflows or Platforms
        • Table Selected Companies Developing NGS Sample-to-Answer (Sample-to-Insight) Platforms
      • Rapid Next Generation Sequencing Testing
        • Table Selected Companies Developing Rapid NGS Assays or Platforms
    • Sequencing Applications
      • Research, Drug Discovery and Development
      • Clinical Diagnostic Applications of Sequencing
        • Cancer Diagnostics: NGS Based Tests for Oncology
          • Table Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Oncology
        • Cancer Diagnostics: Liquid Biopsies
          • Table Selected Companies Developing and/or Marketing Liquid Biopsy Assays
        • Genetic Analysis - Inherited Disorders, Prenatal and Postnatal Diagnostics
          • Table Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Genetic Analysis [Inherited Disorders, Prenatal and Postnatal Diagnostics]
        • Infectious Disease Diagnostics
          • Table Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Infectious Diseases
        • Human Leukocyte Antigen (HLA) Testing
          • Table Selected Companies Offering Products/Services for Applications of DNA Sequencing in Human Leukocyte Antigen (HLA) Testing
        • Other Diagnostic Applications of Sequencing
          • Table Selected Companies Offering Products/Services for Applications of Next Generation Sequencing in Other Diagnostic Applications
      • Direct-to-Consumer Genetic Testing Industry
    • Deals - Next Generation Sequencing Companies
      • Investments and Financing Agreements
        • Table Selected Investment and Financing Agreements in Next Generation Sequencing Companies [Includes IT Companies in NGS]
      • Mergers and Acquisitions
        • Table Selected Acquisitions of Next Generation Sequencing Companies [Includes IT Companies in NGS]
      • Other Corporate Agreements and Collaborations
        • Collaborations/Agreements with Diagnostic Companies and/or Clinical Laboratories
          • Table Selected Agreements between Next Generation Sequencing Companies and Diagnostic Companies or Clinical Laboratories [Includes IT Companies in NGS]
          • Table Examples of Diagnostic Companies and Clinical Laboratories That Have Made Agreements in Next Generation Sequencing
        • Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
          • Table Selected Agreements between Next Generation Sequencing Companies and Pharmaceutical or Biopharmaceutical Companies [Includes Contract Research Organizations Providing Services to Pharma Companies]
          • Table Selected Pharmaceutical and Biopharmaceutical Companies Using or Active in Next Generation Sequencing
        • Collaborations/Agreements between Two Companies in Next Generation Sequencing
          • Table Selected Company Agreements between Two Next Generation Sequencing Companies [Includes IT Companies in NGS]
        • Other Company Collaborations/Agreements
          • Table Selected Other Next-Generation Sequencing Company Agreements in Next Generation Sequencing [Includes IT Companies in NGS]
      • Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
        • Table Selected Next Generation Sequencing Company Agreements with Academic or Other Non-Profit Organizations [Includes IT Companies in NGS]
    • Applying Sequencing to Diagnostics - Market Drivers and Challenges
      • Overcoming Technology Hurdles - Sample Preparation and Data Analysis
      • Advances in Next Generation Sequencing Platforms
      • Next Generation Sequencing Market Drivers
        • Advances in Technology
        • Research Market Drivers
        • Increasing Number of Clinical Applications for Next Generation Sequencing
        • Cancer Diagnostic Market Drivers
        • Genetic Analysis [Inherited Disorders, Prenatal and Postnatal Diagnostics] Market Drivers
        • Infectious Disease Diagnostic Market Drivers
        • Market Drivers for Other Segments of the Diagnostic Market
      • Issues and Hurdles Faced by NGS Companies Selling to the Research Market
      • Issues and Hurdles Faced by Clinical Laboratories Doing NGS
      • Regulation of Next Generation Sequencing-Based In Vitro Diagnostic (IVD) Tests
      • Regulation of Companion Diagnostics
      • Complexities of Companion Diagnostic Tests and Corresponding Therapeutic Products; Harmonization of Companion Diagnostic Tests Across a Class of Targeted Therapies
      • Cost and Reimbursement Issues
      • Competition
      • Future Prospects
    • Sequencing Market Analysis
      • Sequencing Market Overview
        • Table Sequencing Market, Worldwide, 2015 and 2020
        • Table Market Share of Sequencing Market, By Company (Instruments, Consumables, Services Relating to Supporting Products)
      • Sequencing Market - Geographical Distribution
        • Table Sequencing Market by Geographical Region, Worldwide, 2015 and 2020 (North America, Europe, Asia, Rest of World, Total Market) (in millions USD)
        • Table Next Generation Sequencing System Ownership by Country, Percentage (United States, China, Germany, UK, South Korea, Spain, Canada, France, Australia, Netherlands, Italy, Taiwan, Brazil, Japan, India, Sweden, Belgium, Denmark, Switzerland, Singapore, Saudi Arabia, Others)
      • Brand Ownership
        • Table Next Generation Sequencing System Ownership by Brand (HiSeq2000, Genome Analyser, Roche 454, ABI SOLiD, Ion Torrent, MiSeq, Ion Proton, Pacific Biosciences, Oxford Nanopore MinION, Polonator, NextSeq)
      • Sequencing Market - Research versus Clinical Use
        • Table Percent of End Users (Academic & Government versus Commercial, Non-Profit & Hospital), 2014, 2015, and 2018 (projected)
      • Sequencing Methods/Applications
        • Table Research Sequencing Market - Types of Sequencing: Targeted or Whole Exome Sequencing versus de novo or Whole Genome Sequencing (2015)
      • Clinical Sequencing Market - Disease Indications
        • Table Clinical Sequencing Market by Disease Category, 2015, Percentage
        • Table Clinical Sequencing Market by Disease Category, 2020, Percentage
      • Analysis of Deals Activity in Next Generation Sequencing
        • Table Investments in Next Generation Sequencing Companies, 2015 and First Half of 2016 (in millions USD)
    • Company Profiles - Next Generation Sequencing Companies
      • 10x Genomics, Inc.
      • 23andMe, Inc.
      • Abbott Laboratories
        • Recent Revenue History
          • Table Abbott Revenues (2013, 2014, 2015)
        • Company Overview - With a Focus on Sequencing
      • ACT Genomics Co., Ltd.
      • Adaptive Biotechnologies Corporation
      • Admera Health
      • Advanced Biological Laboratories (ABL), S.A
      • Agilent Technologies Inc.
        • Recent Revenue History
          • Table Agilent Technologies Revenues (2013, 2014, 2015)
        • Company Overview
      • AltheaDx, Inc.
      • Ambry Genetics Corp.
      • Aperiomics, Inc.
      • Asuragen, Inc.
      • Athena Diagnostics, Inc. (A Quest Diagnostics Business)
      • Base4 Innovation Ltd
      • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
        • Revenue History
        • Company Overview
      • Becton, Dickinson and Company (BD)
        • Recent Revenue History
          • Table Becton, Dickinson and Company (BD) Revenues (2013, 2014, 2015)
        • Company Overview
      • BGI
      • Bina Technologies, Inc. (Part of Roche Sequencing)
      • BioDiscovery, Inc.
      • Biomatters Ltd.
      • bioMérieux SA
        • Recent Revenue History
          • Table bioMérieux Revenues (2013, 2014, 2015)
          • Table bioMérieux Revenues (2014 and 2015) - By Region, and by Technology and Application
        • Company Overview
      • bioTheranostics, Inc.
      • Cancer Genetics, Inc.
        • Recent Revenue History
          • Table Cancer Genetics Revenues (2013, 2014, 2015)
        • Company Overview
      • CareDx, Inc.
        • Recent Revenue History
          • Table CareDx Revenues (2013, 2014, 2015)
        • Company Overview
      • Caris Life Sciences
      • CLC bio (A QIAGEN Company)
      • Color Genomics, Inc.
      • Complete Genomics (A BGI Company)
      • Courtagen Life Sciences, Inc.
      • Cynvenio Biosystems, Inc.
      • DNA Electronics Ltd.
      • Eurofins Genomics
      • Exosome Diagnostics, Inc.
      • Foundation Medicine, Inc.
        • Recent Revenue History
          • Table Foundation Medicine Revenues (2013, 2014, 2015)
        • Company Overview
      • GATC Biotech AG
      • GenapSys, Inc.
      • GenDx
      • GENEWIZ Inc.
      • Genia Technologies, Inc. (Part of Roche Sequencing)
      • Genomic Health, Inc.
        • Recent Revenue History
          • Table Genomic Health Revenues (2013, 2014, 2015)
        • Company Overview
      • Genoptix (A Novartis Company)
      • GnuBIO, Inc. (A Bio-Rad Company)
      • GRAIL
      • Guardant Health, Inc.
      • Helix
      • HTG Molecular Diagnostics
        • Recent Revenue History
          • Table HTG Molecular Diagnostics (2014 and 2015)
        • Company Overview
      • Human Longevity, Inc.
      • Illumina, Inc.
        • Recent Revenue History
          • Table Illumina (2013, 2014, 2015)
        • Company Overview
      • Inivata Ltd.
      • Invitae Corporation
        • Recent Revenue History
          • Table Invitae Corporation Revenues (2013, 2014, 2015) (in thousands of $)
        • Company Overview
      • Invivoscribe Technologies, Inc.
      • Laboratory Corporation of America (LabCorp)
        • Recent Revenue History
          • Table Laboratory Corporation of America (LabCorp) Revenues (2013, 2014, 2015)
        • Company Overview
      • Lasergen, Inc.
      • MolecularMD Corporation
      • Myriad Genetics, Inc.
        • Recent Revenue History
          • Table Myriad Genetics Revenues (2013, 2014, 2015)
        • Company Overview
      • NANTOMICS (Member of the NantWorks ecosystem of companies)
      • Natera, Inc.
      • NeoGenomics, Inc./NeoGenomics Laboratories
        • Recent Revenue History
          • Table NeoGenomics Revenues (2013, 2014, 2015)
        • Company Overview
      • N-of-One, Inc.
      • OncoDNA SA
      • Oncospire Genomics
      • Oxford Nanopore Technologies Ltd.
      • Pacific Biosciences of California, Inc.
        • Recent Revenue History
          • Table Pacific Biosciences Revenues (2013, 2014, 2015)
        • Company Overview
      • Pathway Genomics Corporation
      • Personal Genome Diagnostics, Inc.
      • Personalis, Inc.
      • QIAGEN N.V.
        • Recent Revenue History
          • Table QIAGEN Revenues (2013, 2014, 2015)
          • Table QIAGEN - Distribution of Sales in 2015
        • Company Overview
      • Quest Diagnostics
        • Recent Revenue History
          • Table Quest Diagnostics Revenues (2013, 2014, 2015)
        • Company Overview
      • RainDance Technologies, Inc.
      • Roche
        • Recent Revenue History
          • Table Roche Revenues (2014 and 2015)
        • Company Overview
      • Siemens Healthcare Diagnostics
        • Recent Revenue History
          • Table Siemens Revenues (2014 and 2015)
        • Company Overview
      • Stratos Genomics Inc.
      • Sysmex Corporation
        • Recent Revenue History
          • Table Sysmex Revenues (2013, 2014, 2015)
        • Company Overview
      • Thermo Fisher Scientific, Inc.
        • Recent Revenue History
          • Table Thermo Fisher Scientific Revenues (2013, 2014, 2015)
        • Company Overview

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings